期刊
INTERNATIONAL JOURNAL OF NEONATAL SCREENING
卷 8, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/ijns8030047
关键词
aminoacidemias; fatty acid oxidation disorders; inborn errors of metabolism; newborn screening; organic acidemias; urea cycle defects; tandem mass spectrometry
Newborn screening for inborn errors of metabolism is an advanced tool for early diagnosis and treatment initiation. Italy introduced expanded newborn screening in 2016-2017 and collected data from 15 Italian screening laboratories. Aminoacidemias were the most common inborn errors, and second-tier tests were effective in reducing false positives. The screening also identified conditions related to maternal deficiencies.
Newborn screening (NBS) for inborn errors of metabolism is one of the most advanced tools for secondary prevention in medicine, as it allows early diagnosis and prompt treatment initiation. The expanded newborn screening was introduced in Italy between 2016 and 2017 (Law 167/2016; DM 13 October 2016; DPCM 12-1-2017). A total of 1,586,578 infants born in Italy were screened between January 2017 and December 2020. For this survey, we collected data from 15 Italian screening laboratories, focusing on the metabolic disorders identified by tandem mass spectrometry (MS/MS) based analysis between January 2019 and December 2020. Aminoacidemias were the most common inborn errors in Italy, and an equal percentage was observed in detecting organic acidemias and mitochondrial fatty acids beta-oxidation defects. Second-tier tests are widely used in most laboratories to reduce false positives. For example, second-tier tests for methylmalonic acid and homocysteine considerably improved the screening of CblC without increasing unnecessary recalls. Finally, the newborn screening allowed us to identify conditions that are mainly secondary to a maternal deficiency. We describe the goals reached since the introduction of the screening in Italy by exchanging knowledge and experiences among the laboratories.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据